For patients with a RET oncogene mutation, it is advisable to screen for hyperparathyroidism and pheochromocytoma to rule out multiple endocrine neoplasia type 2 (MEN-2) syndrome [9]. The gene discussed is RET; the disease is hyperparathyroidism.